Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Irinotecan × Thoracic × Clear all

Phase

Status

Completed 49 Unknown 14 Terminated 12 Active not recruiting 4 Recruiting 3 Not yet recruiting 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 22 Sarcoma 3 Other solid neoplasm 2 Gynecologic 2 CNS 2 Breast 2 Thoracic 1 Genitourinary 1

Conditions

Small Cell Lung Carcinoma 1

Interventions

Carboplatin 34 Cisplatin 31 Pemetrexed 30 Radiotherapy 19 Paclitaxel 19 pembrolizumab 18 durvalumab 18 Docetaxel 18 Gemcitabine 15 Nivolumab 14 Radiosurgery 12 Etoposide 10 Erlotinib Hydrochloride 9 atezolizumab 8 Drug Therapy 8 Bevacizumab 8 Taxes 7 Magnetic Resonance Spectroscopy 7 Cyclophosphamide 7 Gefitinib 6 Platinum 5 130-nm albumin-bound paclitaxel 5 sotorasib 4 Surveys and Questionnaires 4 Ramucirumab 4 Immunotherapy 4 Fluorodeoxyglucose F18 4 Biopsy 4 1,2-diaminocyclohexaneplatinum II citrate 4 trametinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04543916 2021-03-03

Venetoclax and Irinotecan in Relapsed/Refractory SCLC

Virginia Commonwealth University

Phase 1/2 Withdrawn

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡